ATS2017閉幕

e0156318_845053.jpg


 私は、個人的な事情で海外の学会には行くことはできません。そのため、日本にいながら、国際学会の情報を収集する必要があります。それを助けてくれるのが、SNSです。

 今年のATSの情報は、昨年と同じくTwitterで収集しました。演題発表中も多くの参加者がパシャパシャと写真を撮影しており、公式SNSアカウントでさえも情報をタイムラインに流している状態です(寛容な国だと思います)。おそらく、来年も同様の傾向でしょう。

e0156318_905966.jpg


 数年前までは、このブログ上でATSやERSの速報ニュースを流していましたが、現在はFacebookページ(URL:Facebook「呼吸器内科医」 https://www.facebook.com/pulmonarist)で速報ニュースを流しています。今回は、50を超えるATSニュースを配信させていただきました。チェックし切れていない方は、Facebookページを下に下に辿れば、さかのぼることができるはずです。Facebookにアカウントを登録しなくても、閲覧することは可能です

 アメリカではFacebook自体はやや下火ですが、Twitterだと配信できるボリュームに限りがあるため、現時点ではFacebookに頼っている状態です。新しいSNSも色々登場しているので、世の動向を察知しながら柔軟に対応していきたいと思っています。

 これからも、呼吸器内科医にとって有用な情報をお届けできるコンテンツサイトであり続けたいと思います。


<ATS2017ニュースで紹介した演題>
・A845- J. McKinnell, et al. Clinical Predictors of Antibiotic Failure in Adult Outpatients with Community-Acquired Pneumonia
・A5060 -K. M. Kunisaki, et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Increase Subsequent Cardiovascular Event Risk: A Secondary Analysis of Adjudicated SUMMIT Study Data
・A1033 - Z. Chen, et al. Increased Physical Activity Associated with Decreased IL-6 and CRP in Patients with COPD.
・A1193 - L. P. Hayden, et al. Childhood Pneumonia Is a Risk Factor for COPD Development but Not Progression in the COPDGene Study
・A8674 - A.A. Diaz, et al. Low Muscle Mass and Mortality in Smokers with and Without COPD
・A6524 - M. Dres, et al. Effect of High Volume ICUs on Mortality in ARDS Over 15 Years.
・A1660 -S. Nuguru, et al. Safety and Efficacy of Endobronchial Ultrasound Guided Transvascular Needle Aspiration(EBUS-TVNA)
・A7408 - J. Hetzel, et al. Bleeding Severity After Transbronchial Cryobiopsies Is Influenced by Body Height and Age
・Patrick B. Murphy, et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD ExacerbationA Randomized Clinical Trial. JAMA. Published online May 21, 2017. (JAMA掲載)
・A1119 -A. Brueder, et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: Diagnostic Yield, Outcomes and Risk Factors for Complications
・A5304 -J.L. Salinas, et al. Factors Associated with Mortality Among Patients with Multidrug-Resistant Tuberculosis--United States, 1993-2013
・A1121 -Z. Hu, et al. Six-Minute-Walk Test (6MWT) and Pulmonary Function in Interstitial Lung Disease (ILD) Patients
・A2846 -S. A. Guler, et al. Prevalence and Predictors of Sarcopenia in Fibrotic Interstitial Lung Disease
・A2672 -J. A. Smith, et al. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Anti-Tussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Study (VOLCANO-1)
・A2671 - J. Cheng, et al. Severity, Predictors, and Impact of Cough in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
・A2733 - G. G. Paul, et al. Lower Serum IgA Is Associated with COPD Exacerbation Risk: SPIROMICS and COPDGene
・A1333 - I. Strambu, et al. Treatment of Acute Exacerbations in COPD: An Exploratory Phase II Study of Single and Repeated Doses of Acumapimod (BCT197), an Oral p38 Inhibitor
・A7570 - E. M. Hessel,, et al. Safety, Pharmacokinetics and Dose-response Characteristics of GSK2269557, an Inhaled PI3Kδ Inhibitor Under Development for the Treatment of COPD
・Christopher W. Seymour, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. NEJM May 21, 2017DOI: 10.1056/NEJMoa1703058 (NEJM掲載)
・Matthew W. Semler, et al. A Multicenter, Randomized Trial of Ramped Position versus Sniffing Position during Endotracheal Intubation of Critically Ill Adults. (Chest掲載)
・A4747 - P. Ungprasert, et al. Sarcoidosis Increases Risk of Hospitalized Infection: A Population-Based Study 1976-2013
・A3536 - J. Wang, et al. Pleural Fluid Lactate Dehydrogenase/Adenosine Deaminase Ratio for the Differentiation of Tuberculous and Parapneumonic Effusions in Pathological Confirmed Patients
・A4748 -P. Ungprasert, et al. Long-Term Outcome of Pulmonary Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013
・A3561 -S. Touray, et al. Incidence of Iatrogenic Complications Following Thoracentesis in an Academic Medical Center
・A3560 -A. Mitani, et al. The Incidence and Risk Factors of Asymptomatic Spontaneous Pneumothorax (ASP) Detected During Health Check-Ups
・A8941-A. Lee, et al. Prenatal Exposure to Fine Particulate Matter Is Associated with Early Childhood Asthma: Influence of Exposure Timing and Effect Modification by Prenatal Stress and Child Sex
・P. Nair, et al. Benralizumab Significantly Reduced Oral Corticosteroid Dosages and Asthma Exacerbation Rates for Patients with Severe, Uncontrolled Asthma: Results of the ZONDA Phase III Trial
・A12608- K.O. Lindell, et al. Equipment, Access and Worry About Running Short of Oxygen: Key Concerns in the Patient Supplemental Oxygen Survey
・A3913- T. Kendzerska, et al. Sleep Apnea Increases the Risk of New Onset Atrial Fibrillation: A Clinical Cohort Study
・Michael E. Wechsler, et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med 2017; 376:1921-1932 (NEJM掲載)
・Katherine N. Cahill, et al. KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma. N Engl J Med 2017; 376:1911-1920(NEJM掲載)
・A5163- G. Bourjeily, et al. Obstructive Sleep Apnea in Pregnancy Is Associated with Adverse Maternal Outcomes: A National Cohort
・A4986 -H. Mullerova, et al. Characterization of COPD Patients Treated with Inhaled Triple Therapy Containing Inhaled Corticosteroids [ICS], Long-Acting Beta2-Agonists [LABA], and Long-Acting Muscarinic Antagonists [LAMA] in the UK
・A5004 - N. Putcha, et al. Anemia Is Associated with a Specific Phenotype Having Worse Outcomes in COPD: Analysis from SPIROMICS
・A6740 - S. V. Kemp, et al. A Multicenter, Prospective, Randomized, Controlled Trial of Endobronchial Valve Treatment vs Standard of Care in Heterogeneous Emphysema (TRANSFORM)
・A6741 -B. J. Make, et al. A Randomized Controlled Trial of AZD7624, an Inhaled p38 MAP Kinase Inhibitor, in COPD Patients on ICS/LABA with a History of Frequent Exacerbations
・A6791 - J. K. Simpson, et al. CYFRA-21-1 as a Biomarker with Prognostic Potential in Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Cohort
・A6797 - Y. L. Li, et al. The Effect of N-Acetylcysteine on Idiopathic Pulmonary Fibrosis: A Meta-Analysis
・A8321- M. Rahouma, et al. Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population based analysis.
・A775 - T. Wilkinson, et al. Online Versus Face to Face Pulmonary Rehabilitation for Patients with COPD: A Randomised Controlled Trial
・A1375- Pathak V, et al. Cocaine Induced Bronchospasm Mimicking Acute Asthma Exacerbation
・A7119 -M. Koslow, et al. Rheumatoid Pulmonary Nodules: Clinical and Imaging Features
・A7009 -K. J. Cummings, et al. Occupational Contribution to Idiopathic Pulmonary Fibrosis
・A7010 - T. M. Maher, et al. A Randomised, Placebo-Controlled, Double-Blind, Repeat Dose Escalation Study with Omipalisib (GSK2126458) in Patients with Idiopathic Pulmonary Fibrosis (IPF)
・A7012 -T. Luckhardt, et al. Frailty as an Outcome Measure in Idiopathic Pulmonary Fibrosis Patients
・A7409 -M. Mohning, et al. Duration of Rheumatoid Arthritis and the Risk of Developing Interstitial Lung Disease
・A7007 -H. E. Jo, et al. Biomarkers Can Predict Disease Progression in Idiopathic Pulmonary Fibrosis: Analysis from the Australian IPF Registry
・A7422 - M. Orcholski, et al. Tankyrase Inhibitors: A Potential Novel Therapy for LAM/TSC
・A7411 - J. Lee, et al. Clinical Characteristics and Prognosis of Interstitial Pneumonia with Autoimmune Features
・Nathan SD, et al. Effect of Pirfenidone on All-Cause Mortality (ACM) and Forced Vital Capacity (FVC) in Idiopathic Pulmonary Fibrosis (IPF) Patients With Low FVC and/or Low DLCO: Analysis of Pooled Data From ASCEND and CAPACITY.
・Glassberg MK, et al. Effect of Pirfenidone on Breathlessness as Measured by the UCSD SOBQ Score in Patients With Idiopathic Pulmonary Fibrosis (IPF) With Moderate Lung Function Impairment
・Lederer D, et al. Effect of pirfenidone on a novel definition of progression-free survival (PFS) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from Phase III trials
・Lalla D, et al. Pirfenidone and Nintedanib compliance and persistence in a real-world setting.
・A5747-G. Chupp, et al. Post-Approval Study for Bronchial Thermoplasty (BT): Results to 2 Years

# by otowelt | 2017-05-26 00:06 | 呼吸器その他

ATS2017 5月24日

Facebookページで取り上げたATSニュースのメモです。

URL:Facebookサイト「呼吸器内科医」 https://www.facebook.com/pulmonarist



<5月24日> News48~News57

・A7119 -M. Koslow, et al. Rheumatoid Pulmonary Nodules: Clinical and Imaging Features
・A7009 -K. J. Cummings, et al. Occupational Contribution to Idiopathic Pulmonary Fibrosis
・A7010 - T. M. Maher, et al. A Randomised, Placebo-Controlled, Double-Blind, Repeat Dose Escalation Study with Omipalisib (GSK2126458) in Patients with Idiopathic Pulmonary Fibrosis (IPF)
・A7012 -T. Luckhardt, et al. Frailty as an Outcome Measure in Idiopathic Pulmonary Fibrosis Patients
・A7409 -M. Mohning, et al. Duration of Rheumatoid Arthritis and the Risk of Developing Interstitial Lung Disease
・A7007 -H. E. Jo, et al. Biomarkers Can Predict Disease Progression in Idiopathic Pulmonary Fibrosis: Analysis from the Australian IPF Registry
・A7422 - M. Orcholski, et al. Tankyrase Inhibitors: A Potential Novel Therapy for LAM/TSC
・A7411 - J. Lee, et al. Clinical Characteristics and Prognosis of Interstitial Pneumonia with Autoimmune Features
・Nathan SD, et al. Effect of Pirfenidone on All-Cause Mortality (ACM) and Forced Vital Capacity (FVC) in Idiopathic Pulmonary Fibrosis (IPF) Patients With Low FVC and/or Low DLCO: Analysis of Pooled Data From ASCEND and CAPACITY.
・Glassberg MK, et al. Effect of Pirfenidone on Breathlessness as Measured by the UCSD SOBQ Score in Patients With Idiopathic Pulmonary Fibrosis (IPF) With Moderate Lung Function Impairment
・Lederer D, et al. Effect of pirfenidone on a novel definition of progression-free survival (PFS) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from Phase III trials
・Lalla D, et al. Pirfenidone and Nintedanib compliance and persistence in a real-world setting.
・A5747-G. Chupp, et al. Post-Approval Study for Bronchial Thermoplasty (BT): Results to 2 Years


# by otowelt | 2017-05-25 07:54 | 呼吸器その他

ATS2017 5月23日

Facebookページで取り上げたATSニュースのメモです。
ATSもあと残り少しです。呼吸器内科医のみなさん、頑張りましょう。

URL:Facebookサイト「呼吸器内科医」 https://www.facebook.com/pulmonarist



<5月22日> News38~News47

・A4986 -H. Mullerova, et al. Characterization of COPD Patients Treated with Inhaled Triple Therapy Containing Inhaled Corticosteroids [ICS], Long-Acting Beta2-Agonists [LABA], and Long-Acting Muscarinic Antagonists [LAMA] in the UK
・A5004 - N. Putcha, et al. Anemia Is Associated with a Specific Phenotype Having Worse Outcomes in COPD: Analysis from SPIROMICS
・A6740 - S. V. Kemp, et al. A Multicenter, Prospective, Randomized, Controlled Trial of Endobronchial Valve Treatment vs Standard of Care in Heterogeneous Emphysema (TRANSFORM)
・A6741 -B. J. Make, et al. A Randomized Controlled Trial of AZD7624, an Inhaled p38 MAP Kinase Inhibitor, in COPD Patients on ICS/LABA with a History of Frequent Exacerbations
・A6791 - J. K. Simpson, et al. CYFRA-21-1 as a Biomarker with Prognostic Potential in Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Cohort
・A6797 - Y. L. Li, et al. The Effect of N-Acetylcysteine on Idiopathic Pulmonary Fibrosis: A Meta-Analysis
・A8321- M. Rahouma, et al. Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population based analysis.
・A775 - T. Wilkinson, et al. Online Versus Face to Face Pulmonary Rehabilitation for Patients with COPD: A Randomised Controlled Trial
・A1375- Pathak V, et al. Cocaine Induced Bronchospasm Mimicking Acute Asthma Exacerbation


# by otowelt | 2017-05-24 07:42 | 呼吸器その他

ATS2017 5月22日

Facebookページで取り上げたATSニュースのメモです。
呼吸器内科医のみなさん、頑張りましょう。

URL:Facebookサイト「呼吸器内科医」 https://www.facebook.com/pulmonarist



<5月22日> News23~News37

・Matthew W. Semler, et al. A Multicenter, Randomized Trial of Ramped Position versus Sniffing Position during Endotracheal Intubation of Critically Ill Adults. (Chest掲載)
・A4747 - P. Ungprasert, et al. Sarcoidosis Increases Risk of Hospitalized Infection: A Population-Based Study 1976-2013
・A3536 - J. Wang, et al. Pleural Fluid Lactate Dehydrogenase/Adenosine Deaminase Ratio for the Differentiation of Tuberculous and Parapneumonic Effusions in Pathological Confirmed Patients
・A4748 -P. Ungprasert, et al. Long-Term Outcome of Pulmonary Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013
・A3561 -S. Touray, et al. Incidence of Iatrogenic Complications Following Thoracentesis in an Academic Medical Center
・A3560 -A. Mitani, et al. The Incidence and Risk Factors of Asymptomatic Spontaneous Pneumothorax (ASP) Detected During Health Check-Ups
・A8941-A. Lee, et al. Prenatal Exposure to Fine Particulate Matter Is Associated with Early Childhood Asthma: Influence of Exposure Timing and Effect Modification by Prenatal Stress and Child Sex
・P. Nair, et al. Benralizumab Significantly Reduced Oral Corticosteroid Dosages and Asthma Exacerbation Rates for Patients with Severe, Uncontrolled Asthma: Results of the ZONDA Phase III Trial
・A12608- K.O. Lindell, et al. Equipment, Access and Worry About Running Short of Oxygen: Key Concerns in the Patient Supplemental Oxygen Survey
・A3913- T. Kendzerska, et al. Sleep Apnea Increases the Risk of New Onset Atrial Fibrillation: A Clinical Cohort Study
・Michael E. Wechsler, et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med 2017; 376:1921-1932 (NEJM掲載)
・Katherine N. Cahill, et al. KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma. N Engl J Med 2017; 376:1911-1920(NEJM掲載)
・A5163- G. Bourjeily, et al. Obstructive Sleep Apnea in Pregnancy Is Associated with Adverse Maternal Outcomes: A National Cohort


# by otowelt | 2017-05-23 08:11 | 呼吸器その他

ATS2017 5月21日

Facebookページで取り上げたATSニュースのメモです。
呼吸器内科医のみなさん、頑張りましょう。

URL:Facebookサイト「呼吸器内科医」 https://www.facebook.com/pulmonarist



<5月21日> News1~News22

・A845- J. McKinnell, et al. Clinical Predictors of Antibiotic Failure in Adult Outpatients with Community-Acquired Pneumonia
・A5060 -K. M. Kunisaki, et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Increase Subsequent Cardiovascular Event Risk: A Secondary Analysis of Adjudicated SUMMIT Study Data
・A1033 - Z. Chen, et al. Increased Physical Activity Associated with Decreased IL-6 and CRP in Patients with COPD.
・A1193 - L. P. Hayden, et al. Childhood Pneumonia Is a Risk Factor for COPD Development but Not Progression in the COPDGene Study
・A8674 - A.A. Diaz, et al. Low Muscle Mass and Mortality in Smokers with and Without COPD
・A6524 - M. Dres, et al. Effect of High Volume ICUs on Mortality in ARDS Over 15 Years.
・A1660 -S. Nuguru, et al. Safety and Efficacy of Endobronchial Ultrasound Guided Transvascular Needle Aspiration(EBUS-TVNA)
・A7408 - J. Hetzel, et al. Bleeding Severity After Transbronchial Cryobiopsies Is Influenced by Body Height and Age
・Patrick B. Murphy, et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD ExacerbationA Randomized Clinical Trial. JAMA. Published online May 21, 2017. (JAMA掲載)
・A1119 -A. Brueder, et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: Diagnostic Yield, Outcomes and Risk Factors for Complications
・A5304 -J.L. Salinas, et al. Factors Associated with Mortality Among Patients with Multidrug-Resistant Tuberculosis--United States, 1993-2013
・A1121 -Z. Hu, et al. Six-Minute-Walk Test (6MWT) and Pulmonary Function in Interstitial Lung Disease (ILD) Patients
・A2846 -S. A. Guler, et al. Prevalence and Predictors of Sarcopenia in Fibrotic Interstitial Lung Disease
・A2672 -J. A. Smith, et al. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Anti-Tussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Study (VOLCANO-1)
・A2671 - J. Cheng, et al. Severity, Predictors, and Impact of Cough in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
・A2733 - G. G. Paul, et al. Lower Serum IgA Is Associated with COPD Exacerbation Risk: SPIROMICS and COPDGene
・A1333 - I. Strambu, et al. Treatment of Acute Exacerbations in COPD: An Exploratory Phase II Study of Single and Repeated Doses of Acumapimod (BCT197), an Oral p38 Inhibitor
・A7570 - E. M. Hessel,, et al. Safety, Pharmacokinetics and Dose-response Characteristics of GSK2269557, an Inhaled PI3Kδ Inhibitor Under Development for the Treatment of COPD
・Christopher W. Seymour, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. NEJM May 21, 2017DOI: 10.1056/NEJMoa1703058 (NEJM掲載)


# by otowelt | 2017-05-22 23:03 | 呼吸器その他